Christopher James Clarke

State University New York Stony Brook

$3,552,668

Attributed

$3,552,668

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $723.6K · FY2021–25

$1M$750K$500K$250K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,552,668 · 2

By mechanism

R01$3,552,668 · 2

Top collaborators

No co-investigators on record.

Most similar at State University New York Stony Brook

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cancer Therapy”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Leonard Freedman · Leidos Biomedical Research, Inc.$71,892,510
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$65,177,437
Martha Hering · Westat, Inc.$57,098,843
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252

Research focus

Cancer TherapyMalignant NeoplasmsMalignant Breast NeoplasmMetabolismPathway InteractionsNeoplasm MetastasisEnzymesIn VitroLoss Of FunctionMediatingNew Therapeutic TargetNovel TherapeuticsSphingolipidsXenograft ModelCell DeathDruggable TargetGenerationsInterestIn VivoInhibitorMediatorBiologyBiological ModelsApoptosis